Analysis of the effect of methyl 2-acetamide-3-methylquinoxaline-7-carboxylate 1,4-di-N-oxide on the relative expression of the trypanothione reductase gene in Trypanosoma cruzi epimastigotes
- PMID: 31551230
Analysis of the effect of methyl 2-acetamide-3-methylquinoxaline-7-carboxylate 1,4-di-N-oxide on the relative expression of the trypanothione reductase gene in Trypanosoma cruzi epimastigotes
Abstract
In recent decades, some quinoxaline 1,4-di-N-oxide derivatives have been shown to have better trypanocidal activity than the reference drugs; however, their mechanism of action is not yet clear, although it is suggested that they mainly produce reactive oxygen species that cause oxidative stress and parasite death. Trypanosoma cruzi relies on the enzyme trypanothione reductase, among others, to defend itself against oxidative stress. With the aim of contributing to the elucidation of the mechanism of action of quinoxaline 1,4-di-N-oxide derivatives on Trypanosoma cruzi, this study was carried out to evaluate the effect of methyl 2-amide-3-methylquinoxaline-7-carboxylate 1,4-di-N-oxide (compound M-8) on the expression of the trypanothione reductase gene in an in vitro model on Trypanosoma cruzi epimastigotes of the CL-Brener strain. The results show that compound M-8 does not cause a significant effect on the trypanothione reductase gene, suggesting a mechanism of action not related to oxidative stress.
Similar articles
-
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives against Trypanosoma cruzi as Trypanothione Reductase Inhibitors.Int J Mol Sci. 2022 Nov 1;23(21):13315. doi: 10.3390/ijms232113315. Int J Mol Sci. 2022. PMID: 36362102 Free PMC article.
-
Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase Inhibitors.Molecules. 2017 Feb 1;22(2):220. doi: 10.3390/molecules22020220. Molecules. 2017. PMID: 28157150 Free PMC article.
-
Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.Redox Biol. 2019 Sep;26:101231. doi: 10.1016/j.redox.2019.101231. Epub 2019 May 28. Redox Biol. 2019. PMID: 31203195 Free PMC article.
-
Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.Curr Med Chem. 2017 May 31;24(11):1066-1138. doi: 10.2174/0929867323666161227094049. Curr Med Chem. 2017. PMID: 28025938 Review.
-
Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.Mini Rev Med Chem. 2017;17(11):939-946. doi: 10.2174/1389557517666170315145410. Mini Rev Med Chem. 2017. PMID: 28302040 Review.
Cited by
-
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives against Trypanosoma cruzi as Trypanothione Reductase Inhibitors.Int J Mol Sci. 2022 Nov 1;23(21):13315. doi: 10.3390/ijms232113315. Int J Mol Sci. 2022. PMID: 36362102 Free PMC article.